In the European Randomized Study of Screening for Prostate cancer, Janssen et al. used IRMA to assay serum free IGF-I (201 pairs) and found no difference in free IGF-I concentrations between prostate cancer cases and matched controls [16]. This evidence concerns the gene IGF1 and prostate cancer.